A detailed history of Gryphon Financial Partners LLC transactions in Amgen Inc stock. As of the latest transaction made, Gryphon Financial Partners LLC holds 4,022 shares of AMGN stock, worth $1.27 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
4,022
Previous 3,954 1.72%
Holding current value
$1.27 Million
Previous $1.12 Million 11.74%
% of portfolio
0.19%
Previous 0.19%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$262.75 - $319.31 $17,867 - $21,713
68 Added 1.72%
4,022 $1.26 Million
Q1 2024

May 01, 2024

BUY
$268.87 - $324.56 $72,594 - $87,631
270 Added 7.33%
3,954 $1.12 Million
Q4 2023

Feb 06, 2024

BUY
$255.7 - $288.46 $703,686 - $793,841
2,752 Added 295.28%
3,684 $1.06 Million
Q3 2023

Nov 07, 2023

BUY
$218.65 - $271.46 $203,781 - $253,000
932 New
932 $250,000
Q1 2023

May 03, 2023

SELL
$225.79 - $275.2 $18,288 - $22,291
-81 Reduced 6.81%
1,109 $268,000
Q4 2022

Feb 08, 2023

SELL
$229.03 - $291.01 $8,474 - $10,767
-37 Reduced 3.02%
1,190 $312,000
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $1,346 - $1,518
-6 Reduced 0.49%
1,227 $276,000
Q2 2022

Jul 28, 2022

BUY
$230.71 - $256.74 $46,834 - $52,118
203 Added 19.71%
1,233 $300,000
Q1 2022

May 05, 2022

SELL
$219.27 - $242.57 $2,192 - $2,425
-10 Reduced 0.96%
1,030 $250,000
Q4 2021

Feb 01, 2022

BUY
$198.88 - $227.6 $8,750 - $10,014
44 Added 4.42%
1,040 $234,000
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $21,863 - $25,616
-103 Reduced 9.37%
996 $212,000
Q2 2021

Aug 13, 2021

BUY
$233.58 - $259.14 $20,555 - $22,804
88 Added 8.7%
1,099 $274,000
Q1 2021

May 05, 2021

BUY
$221.91 - $258.6 $8,876 - $10,344
40 Added 4.12%
1,011 $252,000
Q4 2020

Feb 10, 2021

BUY
$216.38 - $257.67 $865 - $1,030
4 Added 0.41%
971 $223,000
Q3 2020

Nov 16, 2020

BUY
$234.65 - $260.95 $226,906 - $252,338
967 New
967 $246,000
Q1 2020

May 05, 2020

SELL
$182.24 - $241.7 $153,810 - $203,994
-844 Closed
0 $0
Q4 2019

Feb 06, 2020

BUY
$189.21 - $243.2 $159,693 - $205,260
844 New
844 $203,000
Q3 2018

Nov 06, 2018

SELL
$185.29 - $208.89 $72,448 - $81,675
-391 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$166.05 - $186.51 $2,158 - $2,424
-13 Reduced 3.22%
391 $72,000
Q1 2018

May 14, 2018

BUY
$169.43 - $198.0 $24,397 - $28,512
144 Added 55.38%
404 $69,000
Q4 2017

Feb 09, 2018

BUY
$168.79 - $188.59 $43,885 - $49,033
260
260 $45,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Gryphon Financial Partners LLC Portfolio

Follow Gryphon Financial Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gryphon Financial Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gryphon Financial Partners LLC with notifications on news.